Literature DB >> 17291617

The use of chitosan as a flocculant in mammalian cell culture dramatically improves clarification throughput without adversely impacting monoclonal antibody recovery.

Frank Riske1, James Schroeder, Julie Belliveau, Xuezhen Kang, Joseph Kutzko, Manoj K Menon.   

Abstract

Flocculants have been employed for many years as aides in the clarification of wastewater, chemicals and food. Flocculants aggregate and agglutinate fine particles resulting in their settling from the liquid phase and a reduction in solution turbidity. These materials have not been widely used in the clarification of mammalian cell culture harvest. In this paper we examined chitosan as a flocculent of cells and cell particulates in NS0 culture harvest and the subsequent further clarification of this material by continuous flow centrifugation followed by depth and absolute filtration. Chitosan is an ideal flocculant for biotechnology applications as it is produced from non-mammalian sources (typically arthropod shells) and is also available in a highly purified form that is low in heavy metals, volatile organics and microbial materials. Chitosan is a polymer of deacetylated chitin. The deacetylation imparts limited solubility on insoluble chitin and the amino groups on the polymer result in a polycationic material at acidic and neutral pH that can interact with polyanions, such as DNA and cell culture debris (typically negatively charged). Likely the interaction of chitosan with cell culture particulate forms a germinal center for further interaction and agglomeration of particulates thereby reducing the solubility of these materials resulting in their settling out into the solid phase. Chitosan improved the clarification throughput six to seven folds without a deleterious effect on monoclonal antibody recovery or purity. The procedure for utilizing chitosan is facile, easily implemented, and highly effective in improving material clarity and increasing material throughput.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17291617     DOI: 10.1016/j.jbiotec.2006.12.023

Source DB:  PubMed          Journal:  J Biotechnol        ISSN: 0168-1656            Impact factor:   3.307


  14 in total

Review 1.  Recovery and purification process development for monoclonal antibody production.

Authors:  Hui F Liu; Junfen Ma; Charles Winter; Robert Bayer
Journal:  MAbs       Date:  2010-09-01       Impact factor: 5.857

Review 2.  The present state of the art in expression, production and characterization of monoclonal antibodies.

Authors:  Christopher L Gaughan
Journal:  Mol Divers       Date:  2015-08-25       Impact factor: 2.943

3.  Second International Conference on Accelerating Biopharmaceutical Development: March 9-12, 2009, Coronado, CA USA.

Authors:  Janice M Reichert; Nitya Jacob; Ashraf Amanullah
Journal:  MAbs       Date:  2009-05-20       Impact factor: 5.857

4.  A purification process for heparin and precursor polysaccharides using the pH responsive behavior of chitosan.

Authors:  Ujjwal Bhaskar; Anne M Hickey; Guoyun Li; Ruchir V Mundra; Fuming Zhang; Li Fu; Chao Cai; Zhimin Ou; Jonathan S Dordick; Robert J Linhardt
Journal:  Biotechnol Prog       Date:  2015-07-16

5.  Development of a novel and efficient cell culture flocculation process using a stimulus responsive polymer to streamline antibody purification processes.

Authors:  Yun Kenneth Kang; James Hamzik; Michael Felo; Bo Qi; Julia Lee; Stanley Ng; Gregory Liebisch; Behnam Shanehsaz; Nripen Singh; Kris Persaud; Dale L Ludwig; Paul Balderes
Journal:  Biotechnol Bioeng       Date:  2013-06-29       Impact factor: 4.530

6.  PDADMAC flocculation of Chinese hamster ovary cells: enabling a centrifuge-less harvest process for monoclonal antibodies.

Authors:  Thomas McNerney; Anne Thomas; Anna Senczuk; Krista Petty; Xiaoyang Zhao; Rob Piper; Juliane Carvalho; Matthew Hammond; Satin Sawant; Jeanine Bussiere
Journal:  MAbs       Date:  2015       Impact factor: 5.857

7.  Representative mammalian cell culture test materials for assessment of primary recovery technologies: a rapid method with industrial applicability.

Authors:  Daria Popova; Adam Stonier; David Pain; Nigel J Titchener-Hooker; Suzanne S Farid
Journal:  Biotechnol J       Date:  2015-01       Impact factor: 4.677

8.  Evaluation of options for harvest of a recombinant E. Coli fermentation producing a domain antibody using ultra scale-down techniques and pilot-scale verification.

Authors:  Ioannis Voulgaris; Alex Chatel; Mike Hoare; Gary Finka; Mark Uden
Journal:  Biotechnol Prog       Date:  2016-01-12

9.  A highly stable minimally processed plant-derived recombinant acetylcholinesterase for nerve agent detection in adverse conditions.

Authors:  Yvonne J Rosenberg; Jeremy Walker; Xiaoming Jiang; Scott Donahue; Jason Robosky; Markus Sack; Jonathan Lees; Lori Urban
Journal:  Sci Rep       Date:  2015-08-13       Impact factor: 4.379

10.  Scale-down characterization of post-centrifuge flocculation processes for high-throughput process development.

Authors:  Georgina Espuny Garcia Del Real; Jim Davies; Daniel G Bracewell
Journal:  Biotechnol Bioeng       Date:  2014-09-02       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.